ZA895455B - Bu-3608 derivatives - Google Patents

Bu-3608 derivatives

Info

Publication number
ZA895455B
ZA895455B ZA895455A ZA895455A ZA895455B ZA 895455 B ZA895455 B ZA 895455B ZA 895455 A ZA895455 A ZA 895455A ZA 895455 A ZA895455 A ZA 895455A ZA 895455 B ZA895455 B ZA 895455B
Authority
ZA
South Africa
Prior art keywords
alanyl
compounds
derivatives
5alkyl
xylosyl
Prior art date
Application number
ZA895455A
Other languages
English (en)
Inventor
Maki Nishio
Nishio Maki
Masatoshi Kakushima
Kakushima Masatoshi
Masataka Konishi
Konishi Masataka
Toshikazu Oki
Oki Toshikazu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA895455B publication Critical patent/ZA895455B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA895455A 1988-07-19 1989-07-18 Bu-3608 derivatives ZA895455B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/221,144 US4960755A (en) 1988-07-19 1988-07-19 BU-3608 derivatives

Publications (1)

Publication Number Publication Date
ZA895455B true ZA895455B (en) 1991-12-24

Family

ID=22826542

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895455A ZA895455B (en) 1988-07-19 1989-07-18 Bu-3608 derivatives

Country Status (23)

Country Link
US (1) US4960755A (hu)
EP (1) EP0351799B1 (hu)
JP (1) JP2772549B2 (hu)
KR (1) KR970003127B1 (hu)
AT (1) ATE100459T1 (hu)
AU (1) AU622197B2 (hu)
CA (1) CA1337907C (hu)
CS (1) CS274700B2 (hu)
DD (2) DD296081A5 (hu)
DE (1) DE68912438T2 (hu)
DK (1) DK170778B1 (hu)
ES (1) ES2048793T3 (hu)
FI (1) FI92206C (hu)
HU (2) HU205131B (hu)
IE (1) IE62586B1 (hu)
IL (1) IL91001A (hu)
MY (1) MY105128A (hu)
NO (1) NO170544C (hu)
NZ (1) NZ229964A (hu)
PT (1) PT91203B (hu)
RU (2) RU2032693C1 (hu)
YU (1) YU138289A (hu)
ZA (1) ZA895455B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183808A (en) * 1988-11-10 1993-02-02 Bristol-Myers Squibb Company Method for treating fungal infections with serine analogs of BU-3608 antibiotics
US5114857A (en) * 1988-11-10 1992-05-19 Bristol-Myers Company Actinomadura hibisca microorganism useful for preparing serine analogs of BU-3608 antibiotics
JP2643404B2 (ja) * 1989-01-13 1997-08-20 財団法人微生物化学研究会 新抗生物質ｎ―アセチルベナノマイシンｂならびにその製造法
US5098708A (en) * 1990-06-14 1992-03-24 Bristol-Myers Squibb Company Antiviral antibiotic BU-3889V
FI903460A0 (fi) * 1989-07-10 1990-07-09 Bristol Myers Squibb Co Antiviralt antibiotikum bu-3889v.
US5227370A (en) * 1989-11-14 1993-07-13 Bristol-Myers Squibb Company Pradimicin derivatives
FI92207C (fi) * 1989-11-14 1994-10-10 Squibb Bristol Myers Co Menetelmä terapeuttisesti käyttökelpoisten pradimisiinijohdannaisten valmistamiseksi
CA2030166C (en) * 1989-11-22 1997-10-07 Shimpei Aburaki Pradimicin derivatives
US5696096A (en) * 1990-09-28 1997-12-09 Bristol-Myers Squibb Company Pradimicin derivatives
US5843908A (en) * 1990-09-28 1998-12-01 Bristol-Myers Squibb Company Pradimicins l and fl, and derivatives thereof
US5326867A (en) * 1992-07-16 1994-07-05 Bristol-Myers Squibb Company Pradimic acids, amides, and pradimicin derivatives
US5338728A (en) * 1992-08-14 1994-08-16 Bristol-Myers Squibb Pradimicin compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591637A (en) * 1985-01-17 1986-05-27 Sri International Open chain-morpholino adriamycins
US4870165A (en) * 1987-02-02 1989-09-26 Bristol-Myers Company Antifungal antibiotics
US5055453A (en) * 1987-11-02 1991-10-08 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Benanomicins a and antibiotic compositions
JP2512050B2 (ja) * 1987-12-25 1996-07-03 財団法人微生物化学研究会 新規抗かび性抗生物質デキシロシルベナノマイシンｂならびにその製造法
US5696096A (en) * 1990-09-28 1997-12-09 Bristol-Myers Squibb Company Pradimicin derivatives

Also Published As

Publication number Publication date
NO892939D0 (no) 1989-07-18
CA1337907C (en) 1996-01-09
IE62586B1 (en) 1995-02-08
YU138289A (en) 1991-02-28
NO170544B (no) 1992-07-20
FI92206C (fi) 1994-10-10
FI893426A0 (fi) 1989-07-14
JP2772549B2 (ja) 1998-07-02
EP0351799B1 (en) 1994-01-19
HU203112B (en) 1991-05-28
DE68912438T2 (de) 1994-06-01
IE892325L (en) 1990-01-19
NO170544C (no) 1992-10-28
DK170778B1 (da) 1996-01-15
DK354689A (da) 1990-01-20
RU2032693C1 (ru) 1995-04-10
NZ229964A (en) 1991-07-26
HU908256D0 (en) 1991-06-28
HUT51283A (en) 1990-04-28
RU2026302C1 (ru) 1995-01-09
ATE100459T1 (de) 1994-02-15
MY105128A (en) 1994-08-30
KR900001715A (ko) 1990-02-27
FI92206B (fi) 1994-06-30
CS440889A2 (en) 1990-11-14
DD296081A5 (de) 1991-11-21
ES2048793T3 (es) 1994-04-01
IL91001A0 (en) 1990-02-09
CS274700B2 (en) 1991-09-15
DK354689D0 (da) 1989-07-18
EP0351799A2 (en) 1990-01-24
PT91203A (pt) 1990-02-08
DE68912438D1 (de) 1994-03-03
HU205131B (en) 1992-03-30
IL91001A (en) 1995-06-29
FI893426A (fi) 1990-01-20
JPH0273095A (ja) 1990-03-13
US4960755A (en) 1990-10-02
EP0351799A3 (en) 1991-04-24
DD287509A5 (de) 1991-02-28
PT91203B (pt) 1995-03-01
KR970003127B1 (ko) 1997-03-14
NO892939L (no) 1990-01-22
AU622197B2 (en) 1992-04-02
AU3827489A (en) 1990-01-25

Similar Documents

Publication Publication Date Title
IL96882A0 (en) Uracil derivatives and pesticides containing the same as active ingredient
AU6329794A (en) Nitrogen-containing spirocycles
AU667920B2 (en) New piperidine derivatives of benzimidazole
GB9206244D0 (en) Cytotoxic compound from a marine sponge
ZA895455B (en) Bu-3608 derivatives
YU54189A (en) Process for obtaining cephem derivatives and midproducts for the same
HK1012341A1 (en) Pyrrolocarbazole
CA2012081A1 (en) 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi 2 derivatives
AU3703093A (en) Monoquaternary 2,16-bispiperidinylandrostane derivatives
AU6231090A (en) N-azabicyclo(3.3.0)octane amides of aromatic acids
AU5264593A (en) Imidazole derivatives
EP0421668A3 (en) 1,4-dihydro-4-oxo-3-quinolone derivatives as selectively toxic mammalian antibacterial agents
CA2177602A1 (en) N-substituted azabicycloalkane derivatives, their preparation and use